Fair Isaac Corporation (FICO) shares have retreated from recent highs, prompting investors to reassess the valuation of the credit-scoring giant. With the stock down over 13% in the past month, we examine whether the dip presents a strategic entry point or confirms concerns that the rally has run its course.
Defense giant Lockheed Martin secures a pivotal seven-year agreement to dramatically ramp up production of key missile defense systems while launching a new venture aimed at combating wildfires, signaling a dual-track strategy of reinforcing core government business and diversifying into civilian applications.
Terex Corporation's shares have experienced notable swings, declining over 4% last week but gaining nearly 7% in the past month. A fresh look at its valuation through discounted cash flow and peer comparisons suggests the stock may be trading at a significant discount to its intrinsic value.
A new report details how Donald Trump's family has amassed a vast cryptocurrency portfolio, coinciding with a regulatory pullback by the SEC and DOJ. The moves raise questions about conflicts of interest as a Trump-backed venture seeks federal banking approval.
Kofi Ampadu, the partner who led a16z's Talent x Opportunity fund, has left the firm months after the program was paused indefinitely, signaling a potential retreat from structured DEI efforts in venture capital.
Construction giant Skanska has secured a landmark joint venture for a central Oslo redevelopment with Entra, alongside new major contracts in Norway and Finland, reinforcing its strategic pivot towards complex, sustainability-focused projects in the region.
A federal judge has indicated she is likely to dismiss Elon Musk's xAI lawsuit accusing OpenAI of stealing trade secrets, dealing a significant blow to the tech billionaire's legal offensive against his former AI venture.
Chemical and ammunition manufacturer Olin Corporation reported fourth-quarter results that missed internal forecasts, pressured by plant disruptions, supply issues, and a sharp year-end drop in chlorine demand. Executives emphasized cash preservation and cost control while navigating what they term an extended market downturn.
Shareholders of Blue Foundry Bancorp have voted decisively to approve the company's merger agreement with Fulton Financial Corporation, clearing a critical hurdle in the creation of a stronger regional banking entity.
Stryker Corporation's latest earnings report, driven by its MedSurg, Neurotechnology divisions and the Mako surgical robot, has reignited investor debate. With shares near $370 and a bullish fair value estimate of $427, analysts are weighing robust growth against a premium valuation.
Dover Corporation (DOV), the diversified industrial manufacturer, continues to attract heavy institutional investment, driving a remarkable long-term share price appreciation. Strong quarterly earnings and bullish guidance underscore the fundamental strength behind the sustained Big Money inflows.
Venture capital titans Marc Andreessen and Ben Horowitz lead a massive $50.8 million fundraising effort for a new super PAC, 'Leading the Future,' aiming to shape AI-friendly policies in the 2026 elections.
Yong Rong (HK) Asset Management has placed a concentrated bet on online brokerage Webull Corporation, making it the fund's largest U.S. equity holding and signaling confidence in the platform's long-term prospects amid a challenging market.
Analyst firm Argus has raised its price target for Sanmina Corporation (SANM) to $200, maintaining a Buy rating following the company's better-than-expected Q1 2026 results and robust positioning in key growth markets.
Dover Corporation topped revenue and profit forecasts for the fourth quarter, fueled by robust order growth in climate tech and retail segments. However, shares dipped as management issued a guarded outlook for the coming year, citing input cost pressures and macroeconomic uncertainty.
Moody's Corporation bolsters its risk analytics arsenal with strategic acquisitions of Numerated Growth Technologies and CAPE Analytics, positioning itself at the center of a private credit market under the regulatory microscope.
Analyst Tara Bancroft of TD Cowen lowered the firm's price target on Geron Corporation (GERN) from $4 to $3, maintaining a Buy rating ahead of the biotech's fourth-quarter results. The move reflects a model update as the company navigates mixed commercial progress for its blood cancer drug RYTELO.
Oshkosh Corporation topped revenue expectations in its latest quarter, but profit fell short as tariffs and cost pressures squeezed margins. The specialty vehicle maker's 2026 outlook balances targeted growth in some segments against persistent challenges in construction markets.
Guggenheim analyst Subbu Nambi raises her price target on Bruker Corporation (BRKR) from $53 to $58, maintaining a Buy rating and projecting nearly 25% upside, as the life sciences tools sector shows resilience.
Brunswick Corporation surpassed Q4 revenue and profit expectations, buoyed by stabilizing retail demand. However, a cautious near-term forecast and persistent tariff headwinds cloud its 2026 trajectory, highlighting the complex currents facing the marine industry.
